Shire PLC said Monday it named David Stout, former president of pharmaceutical operations at GlaxoSmithKline (NYSE: GSK), to the drug developer's board of directors, according to Associated Press.
Best Damn Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Stock Newsletter.
Stout is also on the boards at Allos Therapeutics Inc. (NASDAQ: ALTH), Jabil Circuit Inc. (NYSE: JBL) and Airgas Inc. (NYSE: ARG).
Sign up for the free Best Damn Penny Stocks newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
About Best Damn Penny Stocks
Best Damn Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
